Search results for "Infectious diseases"
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
Most specialty e-consults appropriate, reduced in-person visits in one health system
A study found that about 70% of electronic consultations to five high-volume specialties were appropriate, ranging from 61% for rheumatology to 78% for psychiatry.
https://immattersacp.org/weekly/archives/2020/04/14/5.htm
14 Apr 2020
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
https://immattersacp.org/weekly/archives/2021/10/19/2.htm
19 Oct 2021
CDC releases interim monkeypox guidance, reports epidemiologic and clinical characteristics
The interim guidance focused on prevention and treatment of monkeypox in persons with HIV infection. The most frequently reported signs and symptoms from recent cases of monkeypox in the U.S. include rash (100%), fever (63%), chills (59%), and lymphadenopathy (59%).
https://immattersacp.org/weekly/archives/2022/08/16/1.htm
16 Aug 2022
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
Busting COVID-19 vaccination myths
Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
https://immattersacp.org/archives/2021/11/busting-covid-19-vaccination-myths.htm
1 Nov 2021
Internal Medicine Meeting 2021: Virtual Experience to feature three plenary speakers, including Dr. Anthony Fauci
Join ACP for internal medicine's most comprehensive educational program in a new, engaging, interactive, and virtual format.
https://immattersacp.org/weekly/archives/2021/02/23/6.htm
23 Feb 2021
Coadministration of zoster vaccine, COVID-19 booster appears safe, effective
An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023